Real-World Observational Study on Vildagliptin With Insulin (VIL-INS) or Vildagliptin and Metformin With Insulin (VIL-MET-INS) Therapy in Indian Patients With Type 2 Diabetes Mellitus

被引:1
作者
Panneerselvam, P. [1 ]
Biswas, Dibakar [2 ]
Singh, Hema [3 ]
Kumar, K. Dilip [4 ]
Kumar, P. Ravi [5 ]
Kalra, Pramila [6 ]
Revankar, Santosh [7 ]
Warrier, Sona [7 ]
机构
[1] Aruna Diabet Ctr, Chennai, India
[2] Dr D Biswas Clin, Diabet & Endocrinol, Kolkata, India
[3] Dr Hemas Clin, Diabet & Endocrinol, Jaipur, India
[4] Careful Diagnost Ctr, Diabet & Endocrinol, Kolkata, India
[5] RK Diabet & Endocrinol Ctr, Diabet & Endocrinol, Ranchi, India
[6] Pramilas Clin, Diabet & Endocrinol, Bengaluru, India
[7] USV Pvt Ltd, Sci Serv, Mumbai, India
关键词
uncontrolled hyperglycemia; oral anti-diabetic agents; vildagliptin and metformin treatment; weight loss; tolerability; hba1c; diabetes; ADD-ON THERAPY; GLYCEMIC CONTROL; EFFICACY; COMBINATION; SAFETY;
D O I
10.7759/cureus.47190
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: The therapeutic use of vildagliptin and insulin (VIL-INS) or vildagliptin and metformin in combination with insulin (VIL-MET-INS) in the Indian scenario has yet to be explored by generating real-world evidence. Therefore, the present study aimed to evaluate the demographic, clinical characteristics, and treatment patterns of patients with type 2 diabetes mellitus (T2DM) in Indian settings in the above context.Methodology: This observational study conducted at 600 healthcare centers in India retrospectively analyzed data of adult patients with T2DM who had been treated with either vildagliptin with insulin or a combination of vildagliptin and metformin with insulin. Data were collected from medical records and analyzed by appropriate statistical tests.Results: A total of 12,603 patients with T2DM were included with a mean age of 53.4 years of which 63.8% were males. The majority of patients (n=6511; 51.7%) received a combination of vildagliptin and metformin on top of insulin. A significantly high proportion of patients in the age group of 18-40 years received this treatment compared to patients who were initiated on insulin treatment after vildagliptin and metformin combination (11.6% vs. 9.7%; P<0.001). Of all the patients, 70.0% were able to achieve target glycemic control with either VIS-INS or VIL-MET-INS. After treatment with VIL-INS or VIL-MET-INS, the mean glycated hemoglobin (HbA1c) levels significantly decreased with a mean change of 1.46%. Out of all patients, 13.5% experienced weight changes during treatment, with 67.4% of them showing weight loss. A total of 68 patients reported hypoglycemic events and among them, 49 patients had mild hypoglycemic events. Physician global evaluation of efficacy and tolerability showed a majority of patients rated their experience as good to excellent (86.3% and 86.0%, respectively).Conclusion: Both treatment regimens were effective in terms of reduced HbA1c to achieve glycemic control. Furthermore, it is well tolerated without an increase in the risk of hypoglycemia or weight gain. Hence, this therapy has favorable outcomes for T2DM management in Indian clinical settings.
引用
收藏
页数:15
相关论文
共 50 条
[41]   Real-life safety and efficacy of vildagliptin as add-on to metformin in patients with type 2 diabetes in Turkey - GALATA study [J].
Ayvaz, Goksun ;
Keskin, Lezzan ;
Akin, Fulya ;
Dokmetas, Hatice Sebile ;
Tasan, Ertugrul ;
Ar, Idilhan Baloglu ;
Uren, Emel .
CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (04) :623-632
[42]   Efficacy of Polyethylene Glycol Loxenatide in Combination with Basal Insulin in Patients with Type 2 Diabetes Mellitus: A Retrospective Real-World Study [J].
Liu, Xiaohuan ;
Zhang, Ying ;
Zhao, Li-ling ;
Duan, Yale ;
Hu, Zhizhen ;
Bao, Liya ;
Jin, Ping .
DIABETES THERAPY, 2025, 16 (08) :1581-1592
[43]   iGlarLixi versus basal plus Rapid-Acting insulin in adults with type 2 diabetes advancing from basal insulin therapy: The SoliSimplify Real-World study [J].
McCrimmon, Rory J. ;
Cheng, Alice Y. Y. ;
Galstyan, Gagik ;
Djaballah, Khier ;
Li, Xuan ;
Coudert, Mathieu ;
Frias, Juan P. .
DIABETES OBESITY & METABOLISM, 2023, 25 (01) :68-77
[44]   Insulin Therapy Is Associated With an Increased Risk of Carotid Plaque in Type 2 Diabetes: A Real-World Study [J].
Ke, Jiang-Feng ;
Wang, Jun-Wei ;
Zhang, Zhi-Hui ;
Chen, Ming-Yun ;
Lu, Jun-Xi ;
Li, Lian-Xi .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
[45]   The effect of vildagliptin relative to sulfonylurea as dual therapy with metformin (or as monotherapy) in Muslim patients with type 2 diabetes fasting during Ramadan in the Middle East: the VIRTUE study [J].
Hassoun, Ahmed A. K. ;
Al-Arouj, Monira ;
Ibrahim, Mohamed .
CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (01) :161-167
[46]   Vildagliptin as add-on therapy to insulin improves glycemic control without increasing risk of hypoglycemia in Asian, predominantly Chinese, patients with type 2 diabetes mellitus [J].
Ning, Guang ;
Wang, Weiqing ;
Li, Ling ;
Ma, Jianhua ;
Lv, Xiaofeng ;
Yang, Ming ;
Wang, Wei ;
Woloschak, Michael ;
Lukashevich, Valentina ;
Kothny, Wolfgang .
JOURNAL OF DIABETES, 2016, 8 (03) :345-353
[47]   Real-World Effectiveness of Sitagliptin as Add-On Therapy in Patients With Type 2 Diabetes Mellitus [J].
Chen, Tse-Ying ;
Hsieh, Ching-Jung .
POSTGRADUATE MEDICINE, 2014, 126 (03) :205-215
[48]   Current status of metformin in addition to insulin therapy in adult patients with type 1 diabetes mellitus: An analysis from the Guangdong Type 1 Diabetes Mellitus Translational Medicine Study [J].
Qiu, Liling ;
Ling, Ping ;
Yang, Daizhi ;
Luo, Sihui ;
Zheng, Xueying ;
Liang, Hua ;
Yuan, Yong ;
Liang, Ganxiong ;
Xu, Wen ;
Yao, Bin ;
Yan, Jinhua ;
Weng, Jianping .
JOURNAL OF DIABETES, 2020, 12 (10) :754-760
[49]   Metabolic Control and Adherence to Therapy in Type 2 Diabetes Mellitus Patients Using IDegLira in a Real-World Setting [J].
Melzer-Cohen, Cheli ;
Chodick, Gabriel ;
Naftelberg, Shiran ;
Shehadeh, Naim ;
Karasik, Avraham .
DIABETES THERAPY, 2020, 11 (01) :185-196
[50]   Safety and Clinical Outcomes of Insulin Degludec in Korean Patients with Diabetes in Real-World Practices: A Prospective, Observational Study [J].
Byung Wan Lee ;
Kyu Jeung Ahn ;
Ho Chan Cho ;
Eun Young Lee ;
KyungWan Min ;
Amine Dahaoui ;
Jin Sook Jeong ;
Hyo Jin Lim ;
Hak Chul Jang .
Diabetes Therapy, 2023, 14 :1659-1672